Article Details

BioNTech, Fosun Omicron-adapted booster gets approval in Hong Kong for aged 12 and above

Retrieved on: 2022-12-23 10:37:04

Tags for this article:

Click the tags to see associated articles and topics

BioNTech, Fosun Omicron-adapted booster gets approval in Hong Kong for aged 12 and above. View article details on hiswai:

Excerpt

BioNTech (BNTX) and Shanghai Fosun Pharmaceutical (Group) (SFOSF) said their mono and bivalent COVID-19 vaccine Comirnaty was approved in Hong ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up